Search research articles
Contact Us
Filters
Showing results (281-290 of 323) with videos related to
Page
of 33
Sort By:
European Urology
|
December 13, 2016
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
Sergio Fernández-Pello, Fabian Hofmann, Rana Tahbaz, et al.
European Urology Oncology
|
April 5, 2020
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel
Yasmin Abu-Ghanem, Sergio Fernández-Pello, Axel Bex, et al.
European Urology Oncology
|
June 8, 2019
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
Sergio Fernández-Pello, Milan Hora, Teele Kuusk, et al.
European Urology
|
June 2, 2019
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
Laurence Albiges, Tom Powles, Michael Staehler, et al.
World Journal of Urology
|
April 26, 2015
En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor
Mario W Kramer, Jens J Rassweiler, Jan Klein, et al.
European Urology Focus
|
May 22, 2025
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis
Tamás Fazekas, Marcin Miszczyk, Alexander Giesen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
Johannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
European Urology
|
February 27, 2019
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
Börje Ljungberg, Laurance Albiges, Yasmin Abu-Ghanem, et al.
European Urology
|
September 12, 2018
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
Axel Bex, Laurence Albiges, Michael Staehler, et al.
British Journal of Cancer
|
October 4, 2017
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
Daley S Morera, Martin S Hennig, Asif Talukder, et al.
Page
of 33
Search research articles
Search
Showing results (281-290 of 323) with videos related to
Sort By:
Page
of 33
European Urology
|
December 13, 2016
A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma
Sergio Fernández-Pello, Fabian Hofmann, Rana Tahbaz, et al.
European Urology Oncology
|
April 5, 2020
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel
Yasmin Abu-Ghanem, Sergio Fernández-Pello, Axel Bex, et al.
European Urology Oncology
|
June 8, 2019
Management of Sporadic Renal Angiomyolipomas: A Systematic Review of Available Evidence to Guide Recommendations from the European Association of Urology Renal Cell Carcinoma Guidelines Panel
Sergio Fernández-Pello, Milan Hora, Teele Kuusk, et al.
European Urology
|
June 2, 2019
Updated European Association of Urology Guidelines on Renal Cell Carcinoma: Immune Checkpoint Inhibition Is the New Backbone in First-line Treatment of Metastatic Clear-cell Renal Cell Carcinoma
Laurence Albiges, Tom Powles, Michael Staehler, et al.
World Journal of Urology
|
April 26, 2015
En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor
Mario W Kramer, Jens J Rassweiler, Jan Klein, et al.
European Urology Focus
|
May 22, 2025
Androgen Receptor Pathway Inhibitor Monotherapy in Prostate Cancer: Safety, Oncologic Outcomes, and Quality of Life-A Systematic Review and Meta-analysis
Tamás Fazekas, Marcin Miszczyk, Alexander Giesen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 29, 2016
Pan-Cancer Analysis of the Mediator Complex Transcriptome Identifies CDK19 and CDK8 as Therapeutic Targets in Advanced Prostate Cancer
Johannes Brägelmann, Niklas Klümper, Anne Offermann, et al.
European Urology
|
February 27, 2019
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update
Börje Ljungberg, Laurance Albiges, Yasmin Abu-Ghanem, et al.
European Urology
|
September 12, 2018
A Joint Statement from the European Association of Urology Renal Cell Cancer Guidelines Panel and the International Kidney Cancer Coalition: The Rejection of Ipilimumab and Nivolumab for Renal Cancer by the Committee for Medicinal Products for Human Use Does not Change Evidence-based Guideline Recommendations
Axel Bex, Laurence Albiges, Michael Staehler, et al.
British Journal of Cancer
|
October 4, 2017
Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets
Daley S Morera, Martin S Hennig, Asif Talukder, et al.
Page
of 33